• Curreli, Francesca, Sofia MB Victor, Shahad Ahmed, Aleksandra Drelich, Xiaohe Tong, Chien-Te K. Tseng, Christopher D. Hillyer, and Asim K. Debnath. Mbio 11, no. 6 (2020): e02451-20.

    We have synthesized (CPC Scientific, Inc.) four stapled peptides, as depicted in Figure 2. We also synthesized the linear peptide, NYBSP-C, as a control. Besides, we purchased a linear peptide, SBP1, to use as a control, which was reported recently to bind to SARS-CoV-2 RBD with high affinity (KD = 47nM).

  • Skerratt, Sarah E., Sian Humphreys, Rita Ferreira, Csilla Jorgensen, Joe Warmus, Lei Zhao, Xiaohe Tong, and Sarah A. Nickolls. MedChemComm 7, no. 8 (2016): 1564-1571.

    1. Pfizer Neusentis, The Portway Building, Granta Park, Cambridge, UK.
    2. Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, USA.
    3. CPC Scientific Inc., 1245 Reamwood Avenue, Sunnyvale, CA 94089, USA.

    "antipeptide (EGVYVHPV), angiotensin II, human (DRVYIHPF), and isotopically (13C) labeled heptapeptide (AAAAHAA-NH2 [where “A” indicates a carbon thirteen (13C) "Synthesis was conducted at CPC Scientific Inc. Ac-Asp(OtBu)-Thr(tBu)-His(Trt)-Phe-Pro-Ile-Cys(Trt)-Ile-PhePEG3-Arg(Pbf)-Arg(Pbf)-Lys(Boc)-wang resin (2).. Ac-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-PEG3-Arg-Arg-Lys(BODIPY_TMR_C6)."

    Published On: August 1st, 2016Categories: Citations, coauthored, Metal Chelates, PEGylation, publications
  • Francesca Curreli, Kashfia Haque, Lihua Xie, Qian Qiu, Jinfeng Xu, Weizhong Yong, Xiaohe Tong, Asim K. Debnath. Bioorganic & Medicinal Chemistry 23.24 (2015): 7618-7628.

    To date only two entry inhibitors are available, Maraviroc which targets the co-receptor CCR5 3;4 and Enfuvirtide, a peptide drug which interacts with the N-terminal heptad repeat of gp41 of HIV to form an inactive hetero six-helix bundle preventing infection of host cells 5;6. Despite the success achieved with the HAART the emergence of resistant viruses and the side effects of these therapies highlight the need of novel anti-retroviral agents to overcome these problems.

    Published On: November 10th, 2015Categories: coauthored, publications
  • Hongtao Zhang, Francesca Curreli, Abdul A Waheed, Peter Y Mercredi, Mansi Mehta, Pallavi Bhargava, Daniel Scacalossi, Xiaohe Tong, Shawn Lee, Alan Cooper, Michael F Summers, Eric O Freed & Asim K Debnath Retrovirology 10.1 (2013).

    In this report, we expanded the study to i,i+7 hydrocarbon-stapled peptides to delineate their mechanism of action and antiviral activity. We identified three potent inhibitors, NYAD-36, -66 and -67, which showed strong binding to CA in NMR and isothermal titration calorimetry (ITC) studies and disrupted the formation of mature-like particles. They showed typical α-helical structures and penetrated cells; however, the cell penetration was not as efficient as observed with the i,i+4 peptides.

    Published On: November 15th, 2013Categories: Citations, coauthored, publications, Stapled Peptides
  • Capon, D.J., Kaneko, N., Yoshimori, T., Shimada, T., Wurm, F.M., Hwang, P.K., Tong, X., Adams, S.A., Simmons, G., Sato, T.A. and Tanaka, K. Proceedings of the Japan Academy, Series B 87, no. 9 (2011): 603-616.

    All peptides used in this study (Table 1) were synthesized by an Fmoc/t-Butyl solid-phase strategy on a 2-chlorotrityl chloride resin preloaded with the Fmoc-Thr(tBu)-OH. Amino acid derivatives were obtained from CPC Scientific (Sunnyvale, CA)

    Published On: November 11th, 2011Categories: coauthored, publications